» Articles » PMID: 9448955

Prevalence of Doping in Sports: Doping Control in Norway, 1977-1995

Overview
Specialty Orthopedics
Date 1998 Feb 4
PMID 9448955
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the results from doping controls conducted by the Norwegian Confederation of Sport (NCS) from 1977 to 1995.

Methods: Data were collected by combining three computerized databases and manual records on samples taken and results from analyses in the International Olympic Committee (IOC)-accredited laboratories in London, Huddinge, Cologne, and Oslo. Samples were declared positive if they contained any banned substance on the IOC list that was in effect at any given time.

Results: A total of 15,208 samples were taken; most of them (12,870; 85%) were from Norwegian athletes (90% unannounced tests) belonging to national federations under NCS jurisdiction (NCS members), 461 (3%) were from external Norwegian athletes (either users of private gyms or athletes in organized sports federations not affiliated with the NCS), and 1,874 (12%) were from foreign athletes (three cases with unknown affiliation). There were 130 positive samples and 24 refusals among NCS members (1.2%; men, 1.4%; women, 0.3%), 86 positive samples and 8 refusals among external Norwegian athletes (20%; men, 24%; women, 8%), and 39 positive samples and 1 refusal among foreign athletes (1.6%; men, 2.1%; women, 0.7%). A gradual decrease in the percentage of positive samples was observed among NCS members as testing frequency was increased gradually from 1987 to 1995 in the three high-prevalence sports: powerlifting, weightlifting, and athletics.

Conclusion: An increase in the test frequency of doping tests was associated with a decrease in the percentage of positive samples in targeted sports.

Citing Articles

Doping Prevalence in Competitive Sport: Evidence Synthesis with "Best Practice" Recommendations and Reporting Guidelines from the WADA Working Group on Doping Prevalence.

Gleaves J, Petroczi A, Folkerts D, de Hon O, Macedo E, Saugy M Sports Med. 2021; 51(9):1909-1934.

PMID: 33900578 DOI: 10.1007/s40279-021-01477-y.


Prevalence of doping use in elite sports: a review of numbers and methods.

de Hon O, Kuipers H, van Bottenburg M Sports Med. 2014; 45(1):57-69.

PMID: 25169441 DOI: 10.1007/s40279-014-0247-x.


National Athletic Trainers' Association position statement: anabolic-androgenic steroids.

Kersey R, Elliot D, Goldberg L, Kanayama G, Leone J, Pavlovich M J Athl Train. 2012; 47(5):567-88.

PMID: 23068595 PMC: 3465038. DOI: 10.4085/1062-6050-47.5.08.


Perspectives in the utilisation of Fourier-transform infrared spectroscopy of serum in sports medicine: health monitoring of athletes and prevention of doping.

Petibois C, Deleris G, Cazorla G Sports Med. 2000; 29(6):387-96.

PMID: 10870865 DOI: 10.2165/00007256-200029060-00002.


Women's greatest handicaps: sex, medicine, and men.

Cashmore E Br J Sports Med. 1999; 33(2):76-7.

PMID: 10205685 PMC: 2644057.